Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00308737
Other study ID # MKC-TI-030
Secondary ID
Status Completed
Phase Phase 3
First received March 28, 2006
Last updated October 9, 2014
Start date June 2005
Est. completion date October 2008

Study information

Verified date October 2014
Source Mannkind Corporation
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

Pulmonary Safety in Diabetics with T/I


Recruitment information / eligibility

Status Completed
Enrollment 2053
Est. completion date October 2008
Est. primary completion date September 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- For All Subjects:

- Nonsmoking

- Body mass index <42 kg/m2

- FEV1 greater than or equal to 70% of predicted , DLco and TLC greater than or equal to 80% of predicted at screening,

- No abnormalities in screening pulmonary radiology

- For Subjects with diabetes mellitus:

- Type 1 or type 2 diabetes for at least 2 years

- HbA1c greater than or equal to 6.6 % and less than or equal to 12.0 %

- For Subjects without abnormalities in glucose control:

- No history of diabetes

- Normal results from a formal glucose tolerance test

Exclusion Criteria:

- History of chronic obstructive pulmonary disease, asthma, or other significant pulmonary disease

- Significant renal, hepatic, or cardiac disease

- Women who are pregnant, lactating, or planning on becoming pregnant

- Subjects who have participated in studies of other investigational drugs within the previous 3 months

- Evidence of severe complications of diabetes

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Drug:
Technosphere® Insulin Inhalation Powder
Inhalation, 15U/30U
Usual Care
Subjects will receive antidiabetes treatment at the discretion of their physicians

Locations

Country Name City State
Canada Finchlea Medical Group Brampton Ontario
Canada Courtice Health Centre Courtice, Ontario Ontario
Canada Parkwood Hospital London Ontario
Canada Quest Clinical Trials Markham Ontario
Canada Sarnia Institute of Clinical Research Sarnia Ontario
Canada The London Road Diagnostic Clinic and Medical Centre Sarnia Ontario
Canada Lifestyle Metabolism Center Thornhill Ontario
Canada Albany Medical Center Toronto Ontario
Canada Lifestyle Metabolism Center (600-118 Eglinton Ave W) Toronto Ontario
Canada Manna Research Toronto Ontario
Czech Republic Diabetologicka ambulance Litomerice CZE
Czech Republic Surgery of Diabetology Melnik CZE
Czech Republic Internal Clinic Ostrava - Poruba CZE
Czech Republic Diabetologicka a interni ambulance Ostrava 1 CZE
Czech Republic Diabetologicka a interni ambulance Ostrava-Kuncice CZE
Czech Republic Surgery of Diabetology Petrovice Prague 15 CZE
Czech Republic FN Motol Interni Klinika Praha 6 CZE
Poland Klinika Endocrinologii Diabetologii I Bialystock POL
Poland Oddzial Chorob Wewnetrznych Bialystock POL
Poland Dzial Badan Klinicznych Malopoiskie Krakow POL
Poland Endokrynologiczno Metaboliczne DIAB_ENDO_MET Krakow POL
Poland III Oddzial Chorob Wewnetrznych Szpital Krakow POL
Poland Oddzial Internistyczny Specjalistyczna Lask POL
Poland Klliniczny nr 1 im Norberta Barlickiego Uniwersytetu Medycznego w Lodzi Lodz POL
Poland Oddzial Diabetologiczny Centrum Lodz POL
Poland Oddzial Wewnetrzny B Lodz POL
Poland Spzital Kolejowy imm Wlodzimierza Roeflera Pruszkow POL
Poland Katedra i Klinika Gastroentereologii i Warsaw POL
Poland Oddzial Chorob Wewnetznych i Diabetologii Warsaw POL
Poland ZPZOZ w Otwocku Szpital Miejski Warsaw POL
Poland Klinika Medycyny Rodzinnej i Chorob Warszawa POL
Russian Federation Kemerovo State Medical Academy of Ministry of Health Kemerovo RUS
Russian Federation NHI Kemerovo Regional Clinical Hospital Kemerovo RUS
Russian Federation Federal State Institution Pulmonology Research Institute of Federal Agency of HC&SD Moscow
Russian Federation Moscow State Medical-Stomatological University City Clinical Hospital # 23 Moscow RUS
Russian Federation Municipal Clinical Hospital #13 Moscow RUS
Russian Federation NI Endrocrinological Research Centre of RAMS In patient replacing technologies department Moscow RUS
Russian Federation NI Moscow Regional Scientific Research Clinical Institute na MF Vladimirsky Moscow RUS
Russian Federation NI Principal Military Clinical Hospital n a academician N.N. Burdenko of the Ministry of Defense Moscow RUS
Russian Federation RAAMS Endocrinology and Diabetology Department Moscow RUS
Russian Federation Russian Academy of Medical Sciences National Research Ctr for Endocrinology Institute of Diabetes Moscow RUS
Russian Federation Russian State Medical University Central Clinical Hospital Russian Science Academy Moscow RUS
Russian Federation Russian State Medical University City Hospital # 4 Moscow RUS
Russian Federation SIH of Moscow City Clinical Hopsital #81 Endocrinology and Diabetology Moscow RUS
Russian Federation Ryazan State Medical University na academician IP Pavlov Ryazan RUS
Russian Federation NEI HPE Smolensk State Medical Academy of FAHSD RNHI Smolensk Regional Clinical Hospital Smolensk RUS
Russian Federation Central Medical Sanitary Unit #122 St Petersburg RUS
Russian Federation Krestovsky Island Medical Institute St Petersburg RUS
Russian Federation Pavlov State Medical Univ of St Petersburg St Petersburg RUS
Russian Federation St Petersburg Medical Academy St Elizabeth Hospital St Petersburg RUS
Russian Federation St Petersburg NHI City Polytclinic #77 City Diabetological Center #4 St Petersburg RUS
Russian Federation St Petersburg NHI Municipal Multi-Speciality Hospital # 2 St. Petersburg RUS
Russian Federation Clinical Pharm Dept of Yaroslavl Clin Hospital Yaroslavl RUS
Russian Federation MHI Clinical Hospital for Emergency Care na NV Soloviev Yaroslavl RUS
Russian Federation NHI Yaroslavl Regional Clinical Hospital Yaroslavl RUS
Russian Federation Yaroslavl Regional Clinical Hospital Yaroslavl RUS
Spain Fundacio Sarda Farriol Barcelona ESP
Spain Hospital Clinic I Provincial Barcelona
Spain Fundacion Jimenez Diaz Servicio Endocrinologia y Nutricion Madrid ESP
Spain Hospital 12 de Octubre Consultas Extremas - Endocrinologia Madrid ESP
Spain Hospital Universitario de la Paz Madrid ESP
Spain Hospital Univ Virgen del Rocío Scio Endocrinología Centro de Diagnosticos Pl Baja Sevilla ESP
Ukraine Bukovinian State Medical University Dept of Clinical Immun Chernivtcy UKR
Ukraine Dniepropetrovsh State Medical Academy Dniepropetrovsk UKR
Ukraine Donetsk State Medical University Donetsk UKR
Ukraine Donetsk State Medical University Donetsk UKR
Ukraine Railway Clinical Hospital on Donetsk Station Donetsk UKR
Ukraine V Danilevsky Inst of Endocrinology Pathology Kharkiv UKR
Ukraine Chair Family Med of National Med University Kiev UKR
Ukraine Medical University at Kiev Center of Endocrinology and Metab Kiev UKR
Ukraine Outpatient Clinic of Family Physician "Rusanovka" Kiev
Ukraine Ukr Scientifically Practical Centre of Endocrine Surgery Kiev UKR
Ukraine Lugansk State Medical University Chair of Hosp Therapy #2 Lugansk UKR
Ukraine Lugansk State Medical University Chair of Therapy #1 Lugansk UKR
Ukraine Chair of Endocrin & Clinical Pharmacology of Lvov State Medical University Lvov UKR
Ukraine Odessa Reg. Clinical Hosp Outpatient Department Odessa UKR
Ukraine Odessa State Med Dept of Family Med and Gen Practice Odessa UKR
Ukraine Odessa State Medical University Dept of Gen Practice and Med Rehab Odessa UKR
Ukraine Public Institution City Policlinic #20 Odessa Odessa
Ukraine Crimean State Medical University Dept of Therapy #1 Simferopol UKR
Ukraine Vinnitsa State Medical University Vinnitsa UKR
United Kingdom Barnsley Hospital Barnsley GBR
United Kingdom Kingthorne Group Practice Doncaster GBR
United Kingdom Manny Cussins Centre Leeds GBR
United Kingdom Royal liverpool University Hospital Liverpool GBR
United Kingdom Clinical Research Centre The Royal London Hospital London GBR
United Kingdom Medinova Research Mount Vernon Hospital Middlesex GBR
United Kingdom Edith Cavel Hospital Diabetes Centre Petersborough GBR
United Kingdom Northern General Hospital Sheffield GBR
United Kingdom West Suffolk Hospital Suffolk GBR
United Kingdom Woolpit Medical Practice Suffolk GBR
United Kingdom Birmingham Heartland Hospital West Midlands GBR
United Kingdom Bradford Hospital Dept of Diabetes & Endocrinology West Yorkshire GBR
United States Lovelace Scientific Resources (Albuquerque) Albuquerque New Mexico
United States New Mexico Clinical Research & Osteoporosis Center Albuquerque New Mexico
United States Southwest Endocrinology Associates Albuquerque New Mexico
United States Executive Health and Research Associates Inc Atlanta Georgia
United States Perimeter Institute for Clinical Research (PICR) Atlanta Georgia
United States Fox Valley Clinical Research Center LLC Aurora Illinois
United States Franklin Square Hospital Baltimore Maryland
United States Health Trends Research LLC Baltimore Maryland
United States Billings Clinic Research Division Billings Montana
United States Physicians Associates of Park Place Brooklyn New York
United States Private Practice Burlingame California
United States Metrolina Medical Research Charlotte North Carolina
United States PPS Clinical Research / Southwest Medical Center Chesterfield Missouri
United States Cedar-Crosse Research Center Chicago Illinois
United States Rapid Medical Research Inc Cleveland Ohio
United States Texas Familicare Clinical Research Colleyville Texas
United States Rockdale Medical Research Associates Conyers Georgia
United States Dallas Diabetes & Endocrine Center Dallas Texas
United States University of Texas Southwestern Medical Center Dallas Texas
United States Private Practice Decatur Georgia
United States Denver VA Medical Center Denver Colorado
United States Kaiser Permanente Denver Colorado
United States Buckingham Family Medicine Doyleston Pennsylvania
United States Atlanta Pharmaceutical Research Center Dunwoody Georgia
United States Healthcare Research Florissant Missouri
United States Diabetes Care & Information Center of New York Flushing New York
United States Saint Agnes Medical Center Fresno California
United States Valley Research Fresno California
United States (Private Practice) Garden Grove California
United States Endocrine Research - Physician's East PA Greenville North Carolina
United States Upstate Pharmaceutical Research Greenville South Carolina
United States East Coast Clinical Research Inc Haverhill Massachusetts
United States Your Doctors Care Hillsborough New Jersey
United States Houston Medical Research Associates Houston Texas
United States Diabetes/Lipid Management Center Huntington Beach California
United States North Atlanta Endocrinology & Diabetes PC Lawrenceville Georgia
United States Michigan Institute of Medicine Livonia Michigan
United States Interlink Research Institute Los Alamitos California
United States Magna Center for Family Medicine Magna Utah
United States Your Diabetes Endocrine Nutrition Group Mentor Ohio
United States Medical Research of Louisiana Metairie Louisiana
United States Alliance Medical Group of Greater Waterbury Middlebury Connecticut
United States Bucks County Clinical Research Morrisville Pennsylvania
United States New Britain General Hosptal c?o Betsy Keller New Britain Connecticut
United States Ochsner Clinic and Foundation New Orleans Louisiana
United States Eastside Comprehensive Medical Center New York New York
United States M.E.R.I. New York New York
United States Hampton Roads Center for Clinical Research Inc Norfolk Virginia
United States Arizona Center for Clinical Research Phoenix Arizona
United States Lovelace Scientific Resources Phoenix Arizona
United States Northwest Medical Center Phoenix Arizona
United States Southwest Health Ltd Research Division Phoenix Arizona
United States North Texas Medical Research Plano Texas
United States New Hope Research of Oregon Portland Oregon
United States Rainier Clinical Research Center Inc Renton Washington
United States Southeastern Endocrine & Diabetes Roswell Georgia
United States Diabetes Care Center Salinas California
United States Davis Family Practice Salt Lake City Utah
United States Radiant Research Salt Lake City Salt Lake City Utah
United States Southeastern PA Med Inst LLC (SMO) Salt Lake City Utah
United States Diabetes & Glandular Disease Research Assoc PA San Antonio Texas
United States San Diego Sports Medicine and Family Health Center San Diego California
United States Dorothy L & James E Frank Diabetes Research Institute San Mateo California
United States Sansum Medical Research Institute Santa Barbara California
United States Encompass Clinical Research Spring Valley California
United States MedEx Healthcare Research Inc St Louis Missouri
United States Mercy Health Research St. Louis Missouri
United States Washington University School of Medicine St. Louis Missouri
United States Premiere Pharmaceutical Research LLC Tempe Arizona
United States Scott & White Hospital and Clinic Temple Texas
United States MODEL Clinical Research Towson Maryland
United States Hopewell Valley Family Medicine PA Trenton New Jersey
United States Canyon Clinical Research Tucson Arizona
United States Arizona Research Associates Tuscon Arizona
United States Deerbrook Medical Associates Vernon Hills Illinois
United States Umdnj-Som Voorhees New Jersey
United States McLennan County Medical Education and Research Foundation Waco Texas
United States Clinical Research Waltham Massachusetts
United States Chase Medical Research, LLC Waterbury Connecticut
United States Clinical Research Department Wenatchee Valley Medical Center Wenatchee Washington
United States Granger Medical Clinic West Valley City Utah
United States Physicians Clinical Research Service (PCRS) (SMO) White Plains New York

Sponsors (1)

Lead Sponsor Collaborator
Mannkind Corporation

Countries where clinical trial is conducted

United States,  Canada,  Czech Republic,  Poland,  Russian Federation,  Spain,  Ukraine,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change From Baseline to Month 24 in Forced Expiratory Volume in 1 Second (FEV1) by MMRM for TI vs Usual Care Change from Baseline to End of Study in FEV1 by MMRM Baseline to Month 24 Yes
Primary FEV1 Decrease of = 15% From Baseline Value at Last Measurement for TI vs Usual Care FEV1 decrease of = 15% from Baseline value at last measurement Baseline to Month 24 Yes
Secondary Change From Baseline to Last Measurement in FEV1 for TI vs Usual Care Change from Baseline to last measurement(Month 24) in FEV1 Baseline to Month 24 Yes
Secondary Change From Baseline to Month 24 in Forced Vital Capacity (FVC) by MMRM Change from Baseline to Month 24 in FVC by MMRM Baseline to Month 24 Yes
Secondary Change From Baseline to Month 24 in Total Lung Capacity (TLC) by MMRM Change from baseline to Month 24 in TLC by MMRM Baseline to Month 24 Yes
Secondary Change From Baseline to Month 24 in Hemoglobin Corrected DLco by MMRM Change from baseline to Month 24 in hemoglobin-corrected DLco by MMRM Baseline to Month 24 Yes
Secondary Forced Vital Capacity (FVC) Decrease of = 15% From Baseline Value at Last Measurement FVC Decrease of =15% from Baseline Value at Last Measurement Baseline to Month 24 Yes
Secondary Total Lung Capacity (TLC) Decrease of = 15% From Baseline Value at Last Measurement TLC Decrease of = 15% from Baseline Value at Last Measurement Baseline to Month 24 Yes
Secondary Hemoglobin-Corrected Diffusing Capacity of the Lung for Carbon Monoxide (DLco) Decrease of = 15% From Baseline Value at Last Measurement Hemoglobin-corrected DLco decrease of = 15% from baseline value at last measurement Baseline to Month 24 Yes
Secondary Hemoglobin-Corrected Diffusing Capacity of the Lung for Carbon Monoxide (DLco) Decrease of >3 ml/Min/mmHg From Baseline Value at Last Measurement Hemoglobin-corrected DLco decrease of >3 ml/min/mmHg from baseline value at last measurement Baseline to Month 24 Yes
Secondary Change From Baseline in Glycated Hemoglobin A1c (HbA1c) at Last Measurement for TI vs Usual Care Change from baseline in HbA1c at last measurement Baseline to Month 24 No
Secondary Change in Weight From Baseline at Month 24 Change from baseline in weight at Month 24 Baseline to Month 24 No
See also
  Status Clinical Trial Phase
Completed NCT01805414 - Breakfast Nutrition and Inpatient Glycemia N/A
Completed NCT01427660 - iDecide.Decido: Diabetes Medication Decision Support Study N/A
Completed NCT02648685 - The Study to Investigate the Contribution of Basal and Postprandial Glucose to Overall Hyperglycemia in T2DM
Completed NCT00141232 - Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes Phase 4
Completed NCT03397225 - A Lifestyle Intervention for Type 2 Diabetes Patients in Kuwait and Its Impact on Glycaemic Control N/A
Completed NCT01837680 - Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy N/A
Completed NCT01336738 - Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus Phase 2
Completed NCT00246987 - A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control Phase 3
Completed NCT01193179 - A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes Phase 3
Completed NCT00857558 - A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes Phase 2
Terminated NCT01350102 - The Relationship of Hemoglobin A1c and Diabetic Wound Healing Phase 4
Completed NCT01624116 - Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes N/A
Completed NCT01634282 - Along-term Study of OPC-262 in Patients With Type 2 Diabetes Phase 3
Withdrawn NCT02222623 - The Inova Type 2 Diabetes Mellitus Study N/A
Recruiting NCT06340854 - A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes Phase 3